MacroGenics Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . MacroGenics
MGNX Stock  USD 2.05  0.13  5.96%   
MacroGenics financial statements provide useful quarterly and yearly information to potential MacroGenics investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on MacroGenics financial statements helps investors assess MacroGenics' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting MacroGenics' valuation are summarized below:
Gross Profit
-51.3 M
Profit Margin
(0.69)
Market Capitalization
136.8 M
Enterprise Value Revenue
2.6941
Revenue
141.3 M
We have found one hundred twenty available fundamental ratios for MacroGenics, which can be analyzed and compared to other ratios and to its peers in the industry. All investors should make sure to check all of MacroGenics last-minute market performance against the performance between 2010 and 2025 to make sure the company can sustain itself down the road. Market Cap is likely to rise to about 565.2 M in 2025, whereas Enterprise Value is likely to drop slightly above 475.5 M in 2025.

MacroGenics Total Revenue

89.68 Million

Check MacroGenics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MacroGenics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 7.3 M, Interest Expense of 1.7 M or Selling General Administrative of 37 M, as well as many indicators such as Price To Sales Ratio of 9.98, Dividend Yield of 0.0 or PTB Ratio of 3.69. MacroGenics financial statements analysis is a perfect complement when working with MacroGenics Valuation or Volatility modules.
  
Check out the analysis of MacroGenics Correlation against competitors.
For more information on how to buy MacroGenics Stock please use our How to Invest in MacroGenics guide.

MacroGenics Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets287.5 M343.2 M255.7 M
Slightly volatile
Total Current Liabilities47.8 M64.5 M45.1 M
Slightly volatile
Other Liabilities56.5 M53.8 M30.3 M
Slightly volatile
Property Plant And Equipment Net32.9 M52.5 M29.8 M
Slightly volatile
Current Deferred Revenue22.3 M24.9 M21.4 M
Pretty Stable
Accounts Payable6.1 M7.4 M6.1 M
Very volatile
Cash146.4 M116.1 M128 M
Slightly volatile
Non Current Assets Total40.8 M54.1 M36.3 M
Slightly volatile
Other Assets1.091.1523.9 M
Pretty Stable
Cash And Short Term Investments224.7 M264.3 M200 M
Slightly volatile
Net Receivables14.4 M11.9 M12.5 M
Slightly volatile
Common Stock Total Equity396 K709.5 K378.3 K
Slightly volatile
Common Stock Shares Outstanding42.1 M71.2 M39.3 M
Slightly volatile
Liabilities And Stockholders Equity287.5 M343.2 M255.7 M
Slightly volatile
Non Current Liabilities Total108.3 M103.2 M45 M
Slightly volatile
Other Current Assets11 M11.4 M9.5 M
Slightly volatile
Other Stockholder Equity774 M1.4 B721.3 M
Slightly volatile
Total Liabilities87.9 M167.7 M85.9 M
Slightly volatile
Property Plant And Equipment Gross161.9 M154.2 M52.6 M
Slightly volatile
Total Current Assets246.7 M289 M219.4 M
Slightly volatile
Short Term Debt3.2 M3.4 M95.1 M
Pretty Stable
Common Stock418.1 K714.1 K380.2 K
Slightly volatile
Property Plant Equipment30.8 M34 M27.1 M
Slightly volatile
Short and Long Term Debt Total41 M39.1 M17.8 M
Slightly volatile
Net Tangible Assets245.6 M163.3 M188.8 M
Slightly volatile
Capital Surpluse817.2 M1.4 B729.1 M
Slightly volatile
Non Current Liabilities Other220.6 K232.2 K9 M
Pretty Stable
Long Term Debt Total254.8 K268.2 K1.2 M
Slightly volatile
Net Invested Capital183.2 M137.4 M251.1 M
Slightly volatile
Net Working Capital172.8 M175.7 M235.5 M
Slightly volatile
Capital Stock610 K714.1 K502.7 K
Slightly volatile
Capital Lease Obligations33.9 M39.1 M31.4 M
Slightly volatile

MacroGenics Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization7.3 M11.1 M6.6 M
Slightly volatile
Selling General Administrative37 M60 M34 M
Slightly volatile
Total Revenue89.7 M67.6 M79 M
Slightly volatile
Other Operating Expenses182.7 M261 M165.3 M
Slightly volatile
Research Development147.1 M191.6 M132.4 M
Slightly volatile
Cost Of Revenue7 M7.4 M79.8 M
Pretty Stable
Total Operating Expenses181 M249.8 M163.2 M
Slightly volatile
Reconciled Depreciation11.2 M11.1 M9 M
Slightly volatile
Net Interest Income10 M9.5 M2.3 M
Slightly volatile
Interest Income11.7 M11.1 M2.6 M
Slightly volatile

MacroGenics Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation13.6 M21.1 M12.4 M
Slightly volatile
Begin Period Cash Flow141 M125.2 M123.1 M
Slightly volatile
Other Cashflows From Financing Activities180.8 M172.2 M39.4 M
Slightly volatile
Depreciation7.3 M11.1 M6.6 M
Slightly volatile
Capital Expenditures1.9 M2 M6.8 M
Very volatile
Total Cash From Financing Activities92.3 M172.9 M85.5 M
Slightly volatile
End Period Cash Flow146.4 M116.1 M128 M
Slightly volatile
Change To Netincome15.8 M26.8 M13.4 M
Slightly volatile
Issuance Of Capital Stock526.7 K554.4 K83.7 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio9.9811.669.3279
Very volatile
Days Sales Outstanding43.8757.9752.5679
Slightly volatile
Average Payables6 M4 M4.4 M
Slightly volatile
Stock Based Compensation To Revenue0.30.280.1653
Slightly volatile
Capex To Depreciation0.20.211.2764
Slightly volatile
EV To Sales8.210.357.7453
Very volatile
Inventory Turnover3.316.061.7777
Slightly volatile
Days Of Inventory On Hand46.3448.7851.5753
Slightly volatile
Payables Turnover1.391.4730.2022
Slightly volatile
Sales General And Administrative To Revenue0.290.390.3619
Slightly volatile
Average Inventory2.1 M2 M801.5 K
Slightly volatile
Research And Ddevelopement To Revenue1.392.551.7137
Slightly volatile
Capex To Revenue0.02570.0270.0819
Very volatile
Cash Per Share6.944.276.0189
Pretty Stable
Days Payables Outstanding430257215
Slightly volatile
Current Ratio4.534.035.2162
Very volatile
Receivables Turnover6.196.5216.618
Slightly volatile
Debt To Equity0.210.20.0943
Slightly volatile
Capex Per Share0.03110.03280.1993
Pretty Stable
Average Receivables2 M2.2 M2.4 M
Slightly volatile
Revenue Per Share1.041.092.5197
Slightly volatile
Interest Debt Per Share0.280.510.3468
Slightly volatile
Debt To Assets0.110.10.0567
Slightly volatile
Operating Cycle88.8107104
Slightly volatile
Days Of Payables Outstanding430257215
Slightly volatile
Long Term Debt To Capitalization0.00680.00770.0084
Slightly volatile
Total Debt To Capitalization0.170.160.0802
Slightly volatile
Debt Equity Ratio0.210.20.0943
Slightly volatile
Quick Ratio4.544.015.227
Very volatile
Net Income Per E B T0.760.90.9122
Very volatile
Cash Ratio3.742.073.2043
Very volatile
Days Of Inventory Outstanding46.3448.7851.5753
Slightly volatile
Days Of Sales Outstanding43.8757.9752.5679
Slightly volatile
Fixed Asset Turnover1.41.485.8342
Slightly volatile
Debt Ratio0.110.10.0567
Slightly volatile
Price Sales Ratio9.9811.669.3279
Very volatile
Asset Turnover0.440.230.4113
Slightly volatile

MacroGenics Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap565.2 M536.2 M675.4 M
Very volatile
Enterprise Value475.5 M475.9 M562.4 M
Very volatile

MacroGenics Fundamental Market Drivers

Cash And Short Term Investments229.8 M

MacroGenics Upcoming Events

20th of March 2024
Upcoming Quarterly Report
View
14th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
20th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About MacroGenics Financial Statements

MacroGenics investors use historical fundamental indicators, such as MacroGenics' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in MacroGenics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue24.9 M22.3 M
Total Revenue67.6 M89.7 M
Cost Of Revenue7.4 M7 M
Stock Based Compensation To Revenue 0.28  0.30 
Sales General And Administrative To Revenue 0.39  0.29 
Research And Ddevelopement To Revenue 2.55  1.39 
Capex To Revenue 0.03  0.03 
Revenue Per Share 1.09  1.04 
Ebit Per Revenue(3.29)(3.13)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
VVisa Class A
CRMSalesforce
CRMSalesforce

Additional Tools for MacroGenics Stock Analysis

When running MacroGenics' price analysis, check to measure MacroGenics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MacroGenics is operating at the current time. Most of MacroGenics' value examination focuses on studying past and present price action to predict the probability of MacroGenics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MacroGenics' price. Additionally, you may evaluate how the addition of MacroGenics to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY